GNRH1 and polycystic ovary syndrome: Furthermore,it is possible that change in GnRH release inhibitors, suchas arginine-phenylalanine-amide (RFamide)-related peptide-3 (RFRP3), may control the hormonal irregularitiesof PCOS.